We showed that lack of AIM2 expression in HCC tissues was significantly correlated with larger tumor volumes, lower differentiation status, more advanced disease stages and more metastasis, which indicated that loss of AIM2 expression in HCC patients contributed to disease progression. Here, AIM2 is linked to hepatocellular carcinoma.